Alpha-Methyldopahydrazine en es it fr

Categoria

Alpha-Methyldopahydrazine Marchi, Alpha-Methyldopahydrazine Analoghi

Alpha-Methyldopahydrazine Marchi miscela

  • Atamet (carbidopa + levodopa)
  • Sinemet (carbidopa + levodopa)
  • Alpha-Methyldopahydrazine Formula chimica

    C10H14N2O4

    Alpha-Methyldopahydrazine RX link

    http://www.rxlist.com/cgi/generic/sinemet.htm

    Alpha-Methyldopahydrazine FDA foglio

    Alpha-Methyldopahydrazine DMS (foglio di materiale di sicurezza)

    Alpha-Methyldopahydrazine Sintesi di riferimento

    Chemerda et al. US Pat. 3,462,536 (1963)

    Alpha-Methyldopahydrazine Peso molecolare

    226.229 g/mol

    Alpha-Methyldopahydrazine Temperatura di fusione

    203-205oC

    Alpha-Methyldopahydrazine H2O Solubilita

    3,8 mg / L

    Alpha-Methyldopahydrazine Stato

    Solid

    Alpha-Methyldopahydrazine LogP

    0.494

    Alpha-Methyldopahydrazine Forme di dosaggio

    Compressa (25 mg)

    Alpha-Methyldopahydrazine Indicazione

    Per il trattamento dei sintomi del morbo di Parkinson idiopatico (paralisi agitante), post-encefalitiche parkinsonismo

    Alpha-Methyldopahydrazine Farmacologia

    Carbidopa, un inibitore della decarbossilasi non competitivo, è usato in associazione con levodopa per il trattamento del morbo di Parkinson.

    Alpha-Methyldopahydrazine Assorbimento

    Rapidamente decarbossilata a dopamina nei tessuti extracerebrali in modo che solo una piccola porzione di una data dose viene trasportato invariato al sistema nervoso centrale.

    Alpha-Methyldopahydrazine Tossicita

    I sintomi di una tossicità carbidopa includono spasmi muscolari, debolezza, spasmi delle palpebre, nausea, vomito, diarrea, un battito cardiaco irregolare, confusione, agitazione, allucinazioni e perdita di coscienza.

    Alpha-Methyldopahydrazine Informazioni paziente

    Carbidopa is used with levodopa to treat Parkinson's disease. Parkinson's disease
    is believed to be related to low levels of a chemical called dopamine (DOE pa meen)
    in the brain. Levodopa (Dopar, Larodopa) is turned into dopamine in the body.
    Carbidopa is used with levodopa to prevent the breakdown (metabolism) of levodopa
    before it can reach the brain and take effect. Carbidopa is only effective if it is
    taken with levodopa. It has no effect if it is used alone. Carbidopa is used with
    levodopa to treat the stiffness, tremors, spasms, and poor muscle control of
    Parkinson's disease. These medications are also used to treat the same muscular
    conditions when they are caused by drugs such as chlorpromazine (Thorazine),
    fluphenazine (Prolixin), perphenazine (Trilafon), and others.

    Alpha-Methyldopahydrazine Atto interessato organismi

    Gli esseri umani e altri mammiferi